The known-unknowns in spinal cord injury, with emphasis on cell-based therapies – a review with suggestive arenas for research

Bibliography

• Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest 2012;122:3824-34
   PubMed Web of Science ®Google Scholar
• Lee BB, Cripps RA, Fitzharris M, Wing PC. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord 2014;52(2):110-16
   PubMed Web of Science ®Google Scholar
• Fassett DR, Harrop JS, Maltenfort M, et al. Mortality rates in geriatric patients with spinal cord injuries. J Neurosurg Spine 2007;7:277-81
   PubMed Web of Science ®Google Scholar
• Priebe MM, Chiodo AE, Scelza WM, et al. Spinal cord injury medicine. 6. Economic and societal issues in spinal cord injury. Arch Phys Med Rehabil 2007;88:S84-8
   PubMed Web of Science ®Google Scholar
• Kan EM, Ling EA, Lu J. Stem cell therapy for spinal cord injury. Curr Med Chem 2010;17:4492-510
   PubMed Web of Science ®Google Scholar
• Akhtar AZ, Pippin JJ, Sandusky CB. Animal models in spinal cord injury: a review. Rev Neurosci 2008;19:47-60
   PubMed Web of Science ®Google Scholar
• Blight AR. Animal models of spinal cord injury. Top Spinal Cord Inj Rehabil 2000;6:1-13
   Google Scholar
• Stokes BT, Jakeman LB. Experimental modelling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology. Spinal Cord 2002;40:101-9
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JK. Animal models of axon regeneration after spinal cord injury. Neurosci Bull 2013;29:436-44
   PubMedGoogle Scholar
• Jones CF, Lee JH, Kwon BK, Cripton PA. Development of a large-animal model to measure dynamic cerebrospinal fluid pressure during spinal cord injury: laboratory investigation. J Neurosurg Spine 2012;16:624-35
   PubMedGoogle Scholar
• William JB, Prabakaran R, Ayyappan S, et al. Functional recovery of spinal cord injury following application of intralesional bone marrow mononuclear cells embedded in polymer scaffold - two year follow-up in a Canine. J Stem Cell Res Ther 2011;1:110
   Google Scholar
• El-Ftesi S, Chang EI, Longaker MT, Gurtner GC. Aging and diabetes impair the neovascular potential of adipose-derived stromal cells. Plast Reconstr Surg 2009;123:475-85
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Cesselli D, Beltrami CA. Stem cell senescence and regenerative paradigms. Clin Pharmacol Ther 2012;91:21-9
   PubMed Web of Science ®Google Scholar
• Dedeepiya VD, Rao YY, Jayakrishnan GA, et al. Index of CD34+ cells and mononuclear cells in the bone marrow of spinal cord injury patients of different age groups: a comparative analysis. Bone Marrow Res 2012;2012:787414
   Google Scholar
• Fujimoto Y, Abematsu M, Falk A, et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012;30:1163-73
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Okada Y, Itakura G, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 2012;7:e52787
   Google Scholar
• Baker M. Stem-cell pioneer bows out. Nature 2011;479:459
   PubMed Web of Science ®Google Scholar
• Inskip JA, Ramer LM, Ramer MS, Krassioukov AV. Autonomic assessment of animals with spinal cord injury: tools, techniques and translation. Spinal Cord 2009;47:2-35
   PubMed Web of Science ®Google Scholar
• Dietz V, Curt A. Translating preclinical approaches into human application. Handb Clin Neurol 2012;109:399-409
   PubMedGoogle Scholar
• Krassioukov A. Autonomic function following cervical spinal cord injury. Respir Physiol Neurobiol 2009;169:157-64
   PubMed Web of Science ®Google Scholar
• Kakizaki H, Kita M, Wada N. Models for sensory neurons of dorsal root ganglia and stress urinary incontinence. Neurourol Urodyn 2011;30:653-7
   PubMed Web of Science ®Google Scholar
• Nout YS, Schmidt MH, Tovar CA, et al. Telemetric monitoring of corpus spongiosum penis pressure in conscious rats for assessment of micturition and sexual function following spinal cord contusion injury. J Neurotrauma 2005;22:429-41
   PubMed Web of Science ®Google Scholar
• Sheets AL, Lai PL, Fisher LC, Basso DM. Quantitative evaluation of 3D mouse behaviors and motor function in the open-field after spinal cord injury using markerless motion tracking. PLoS One 2013;8:e74536
   Google Scholar
• Collinger JL, Foldes S, Bruns TM, et al. Neuroprosthetic technology for individuals with spinal cord injury. J Spinal Cord Med 2013;36:258-72
   PubMed Web of Science ®Google Scholar
• Nout YS, Ferguson AR, Strand SC, et al. Methods for functional assessment after C7 spinal cord hemisection in the rhesus monkey. Neurorehabil Neural Repair 2012;26:556-69
   PubMed Web of Science ®Google Scholar
• Nandoe Tewarie RS, Hurtado A, et al. Stem cell-based therapies for spinal cord injury. J Spinal Cord Med 2009;32:105-14
   PubMed Web of Science ®Google Scholar
• Sun Y, Xu CC, Li J, et al. Transplantation of oligodendrocyte precursor cells improves locomotion deficits in rats with spinal cord irradiation injury. PLoS One 2013;8:e57534
   PubMed Web of Science ®Google Scholar
• All AH, Bazley FA, Gupta S, et al. Human embryonic stem cell-derived oligodendrocyte progenitors aid in functional recovery of sensory pathways following contusive spinal cord injury. PLoS One 2012;7:e47645
   Google Scholar
• Bonner JF, Connors TM, Silverman WF, et al. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J Neurosci 2011;31:4675-86
   PubMed Web of Science ®Google Scholar
• Seledtsova GV, Rabinovich SS, Belogorodtsev SN, et al. Delayed results of transplantation of fetal neurogenic tissue in patients with consequences of spinal cord trauma. Bull Exp Biol Med 2010;149:530-3
   PubMed Web of Science ®Google Scholar
• Kang KS, Kim SW, Oh YH, et al. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 2005;7:368-73
   PubMed Web of Science ®Google Scholar
• Schira J, Gasis M, Estrada V, et al. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain 2012;135:431-46
   PubMed Web of Science ®Google Scholar
• Lee JH, Chung WH, Kang EH, et al. Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury. J Neurol Sci 2011;300:86-96
   PubMed Web of Science ®Google Scholar
• Park SI, Lim JY, Jeong CH, et al. Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. J Biomed Biotechnol 2012;2012:362473
   PubMedGoogle Scholar
• Huang H, Xi H, Chen L, et al. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant 2012;21:S23-31
   Google Scholar
• Syková E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006;15:675-87
   PubMed Web of Science ®Google Scholar
• Deda H, Inci MC, Kürekçi AE, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008;10:565-74
   PubMed Web of Science ®Google Scholar
• Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, Eskandary H. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg 2012;114:935-9
   PubMed Web of Science ®Google Scholar
• Samdani AF, Paul C, Betz RR, et al. Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study. Spine (Phila Pa 1976) 2009;34:2605-12
   PubMed Web of Science ®Google Scholar
• Iwai H, Nori S, Nishimura S, et al. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury. Cell Transplant 2013; published online 30 August 2013, doi:10.3727/096368913X670967
   PubMed Web of Science ®Google Scholar
• Cusimano M, Biziato D, Brambilla E, et al. Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain 2012;135:447-60
   PubMed Web of Science ®Google Scholar
• Bottai D, Madaschi L, Di Giulio AM, Gorio A. Viability-dependent promoting action of adult neural precursors in spinal cord injury. Mol Med 2008;14:634-44
   PubMed Web of Science ®Google Scholar
• A phase I/II study of the safety and preliminary efficacy of intramedullary spinal cord transplantation of human central nervous system (cns) stem cells (hucns-sc) in subjects with thoracic (t2-t11) spinal cord trauma. Available from: http://clinicaltrials.gov/ Clinical Trial Identifier: NCT01321333
   Google Scholar
• A phase 1, open-label, multi-site, safety study of human spinal cord-derived neural stem cell transplantation for the treatment of chronic SCI. Available from: http://clinicaltrials.gov/ Clinical Trial Identifier: NCT01772810
   Google Scholar
• Nakamura M, Okano H. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 2013;23:70-80
   PubMed Web of Science ®Google Scholar
• Fujimoto Y, Abematsu M, Falk A, et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012;30:1163-73
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-15
   PubMed Web of Science ®Google Scholar
• Ronen D, Benvenisty N. Genomic stability in reprogramming. Curr Opin Genet Dev 2012;22:444-9
   PubMed Web of Science ®Google Scholar
• Ambasudhan R, Talantova M, Coleman R, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 2011;9:113-18
   PubMed Web of Science ®Google Scholar
• Kumagai G, Tsoulfas P, Toh S, et al. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol 2013;248:369-80
   PubMed Web of Science ®Google Scholar
• Lin WP, Chen XW, Zhang LQ, et al. Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. PLoS One 2013;8:e63444
   Google Scholar
• Okano H, Nakamura M, Yoshida K, et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 2013;112:523-33
   PubMed Web of Science ®Google Scholar
• Lukovic D, Stojkovic M, Moreno-Manzano V, et al. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury. Stem Cells Dev 2014;23(1):1-4
   PubMed Web of Science ®Google Scholar
• Ess KC. Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells. Exp Biol Med (Maywood) 2013;238:308-14
   PubMed Web of Science ®Google Scholar
• Sadowski D, Kiel ME, Apicella M, et al. Teratogenic potential in cultures optimized for oligodendrocyte development from mouse embryonic stem cells. Stem Cells Dev 2010;19:1343-53
   PubMed Web of Science ®Google Scholar
• Shand J, Berg J, Bogue C, Committee for Pediatric Research; Committee on Bioethics. Human embryonic stem cell (hESC) and human embryo research. Pediatrics 2012;130:972-7
   PubMed Web of Science ®Google Scholar
• Rojansky N, Schenker JG. The use of fetal tissue for therapeutic applications. Int J Gynaecol Obstet 1993;41:233-40
   PubMed Web of Science ®Google Scholar
• Darian-Smith C. Synaptic plasticity, neurogenesis, and functional recovery after spinal cord injury. Neuroscientist 2009;15:149-65
   PubMed Web of Science ®Google Scholar
• Nishimura S, Yasuda A, Iwai H, et al. Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury. Mol Brain 2013;6:3
   PubMed Web of Science ®Google Scholar
• Barbour HR, Plant CD, Harvey AR, Plant GW. Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion. BMC Neurosci 2013;14:106
   PubMedGoogle Scholar
• Plant GW, Christensen CL, Oudega M, Bunge MB. Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma 2003;20:1-16
   PubMed Web of Science ®Google Scholar
• Li J, Lepski G. Cell transplantation for spinal cord injury: a systematic review. Biomed Res Int 2013;2013:786475
   PubMed Web of Science ®Google Scholar
• Boido M, Garbossa D, Vercelli A. Early graft of neural precursors in spinal cord compression reduces glial cyst and improves function. J Neurosurg Spine 2011;15:97-106
   PubMed Web of Science ®Google Scholar
• Kang ES, Ha KY, Kim YH. Fate of transplanted bone marrow derived mesenchymal stem cells following spinal cord injury in rats by transplantation routes. J Korean Med Sci 2012;27:586-93
   PubMed Web of Science ®Google Scholar
• Liu J, Han D, Wang Z, et al. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy 2013;15:185-91
   PubMed Web of Science ®Google Scholar
• Shin DA, Kim JM, Kim HI, et al. Comparison of functional and histological outcomes after intralesional, intracisternal, and intravenous transplantation of human bone marrow-derived mesenchymal stromal cells in a rat model of spinal cord injury. Acta Neurochir (Wien) 2013;155:1943-50
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Tsuji O, Kumagai G, et al. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant 2011;20:727-39
   PubMed Web of Science ®Google Scholar
• Kim JW, Ha KY, Molon JN, Kim YH. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation. Spine (Phila Pa 1976) 2013;38:E1065-74
   Google Scholar
• Cohen DM, Patel CB, Ahobila-Vajjula P, et al. Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed 2009;22:332-41
   PubMed Web of Science ®Google Scholar
• Geffner LF, Santacruz P, Izurieta M, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 2008;17:1277-93
   PubMed Web of Science ®Google Scholar
• Srivastava A, Bapat M, Ranade S, et al. Multiple injections of in vitro expanded autologous bone marrow stem cells for cervical level spinal cord injury- a case report. J Stem Cells Regen Med 2010;6:175-6
   Google Scholar
• Pal R, Gopinath C, Rao NM, et al. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 2010;12:792-806
   PubMed Web of Science ®Google Scholar
• Mautes AE, Weinzierl MR, Donovan F, Noble LJ. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000;80:673-87
   PubMed Web of Science ®Google Scholar
• Pellatt GC. Nontraumatic spinal cord injury part 5: vascular causes and syringomyelia. Br J Neurosci Nurs 2009;5:16-21
   Google Scholar
• Martirosyan NL, Feuerstein JS, Theodore N, et al. Blood supply and vascular reactivity of the spinal cord under normal and pathological conditions. J Neurosurg Spine 2011;15:238-51
   PubMed Web of Science ®Google Scholar
• Ng Michelle TL, Anthea ST, Brian KK. Vascular disruption and the role of angiogenic proteins after spinal cord injury. Transl Stroke Res 2011;2:474-91
   PubMedGoogle Scholar
• Quertainmont R, Cantinieaux D, Botman O, et al. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 2012;7:e39500
   PubMed Web of Science ®Google Scholar
• Ning G, Tang L, Wu Q, et al. Human umbilical cord blood stem cells for spinal cord injury: early transplantation results in better local angiogenesis. Regen Med 2013;8:271-81
   PubMed Web of Science ®Google Scholar
• Lepore AC, Neuhuber B, Connors TM, et al. Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience 2006;142:287-304
   PubMedGoogle Scholar
• Ferrero-Gutierrez A, Menendez-Menendez Y, Alvarez-Viejo M, et al. New serum-derived albumin scaffold seeded with adipose-derived stem cells and olfactory ensheathing cells used to treat spinal cord injured rats. Histol Histopathol 2013;28:89-100
   PubMed Web of Science ®Google Scholar
• Cholas R, Hsu HP, Spector M. Collagen scaffolds incorporating select therapeutic agents to facilitate a reparative response in a standardized hemiresection defect in the rat spinal cord. Tissue Eng Part A 2012;18:2158-72
   PubMed Web of Science ®Google Scholar
• Perale G, Rossi F, Sundstrom E, et al. Hydrogels in spinal cord injury repair strategies. ACS Chem Neurosci 2011;2:336-45
   PubMed Web of Science ®Google Scholar
• Kim BG, Kang YM, Phi JH, et al. Implantation of polymer scaffolds seeded with neural stem cells in a canine spinal cord injury model. Cytotherapy 2010;12:841-5
   PubMed Web of Science ®Google Scholar
• Xia L, Wan H, Hao SY, et al. Co-transplantation of neural stem cells and Schwann cells within poly (L-lactic-co-glycolic acid) scaffolds facilitates axonal regeneration in hemisected rat spinal cord. Chin Med J (Engl) 2013;126:909-17
   PubMed Web of Science ®Google Scholar
• Osanai T, Kuroda S, Yasuda H, et al. Noninvasive transplantation of bone marrow stromal cells for ischemic stroke: preliminary study with a thermoreversible gelation polymer hydrogel. Neurosurgery 2010;66:1140-7
   PubMed Web of Science ®Google Scholar
• Mothe AJ, Tam RY, Zahir T, et al. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials 2013;34:3775-83
   PubMed Web of Science ®Google Scholar
• Li X, Xiao Z, Han J, et al. Promotion of neuronal differentiation of neural progenitor cells by using EGFR antibody functionalized collagen scaffolds for spinal cord injury repair. Biomaterials 2013;34:5107-16
   PubMed Web of Science ®Google Scholar
• Qu J, Wang D, Wang H, et al. Electrospun silk fibroin nanofibers in different diameters support neurite outgrowth and promote astrocyte migration. J Biomed Mater Res A 2013;101:2667-78
   PubMed Web of Science ®Google Scholar
• Giger RJ, Hollis ER II, Tuszynski MH. Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol 2010;2:a001867
   PubMed Web of Science ®Google Scholar
• Comolli N, Neuhuber B, Fischer I, Lowman A. In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair. Acta Biomater 2009;5:1046-55
   PubMed Web of Science ®Google Scholar
• Sykova E, Jendelova P, Urdzikova L, et al. Bone marrow stem cells and polymer hydrogels–two strategies for spinal cord injury repair. Cell Mol Neurobiol 2006;26:1113-29
   PubMed Web of Science ®Google Scholar
• Dewitt DD, Kaszuba SN, Thompson DM, Stegemann JP. Collagen I-matrigel scaffolds for enhanced Schwann cell survival and control of three-dimensional cell morphology. Tissue Eng Part A 2009;15:2785-93
   PubMed Web of Science ®Google Scholar
• Coutts DJ, Humphries CE, Zhao C, et al. Embryonic-derived olfactory ensheathing cells remyelinate focal areas of spinal cord demyelination more efficiently than neonatal or adult-derived cells. Cell Transplant 2013;22:1249-61
   PubMed Web of Science ®Google Scholar
• Yasuda A, Tsuji O, Shibata S, et al. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord. Stem Cells 2011;29:1983-94
   PubMed Web of Science ®Google Scholar
• Abematsu M, Tsujimura K, Yamano M, et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J Clin Invest 2010;120:3255-66
   PubMed Web of Science ®Google Scholar
• Ben-Hur T. Reconstructing neural circuits using transplanted neural stem cells in the injured spinal cord. J Clin Invest 2010;120:3096-8
   PubMed Web of Science ®Google Scholar
• Parr AM, Kulbatski I, Wang XH, et al. Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery. Surg Neurol 2008;70:600-7
   PubMed Web of Science ®Google Scholar
• Shoichet MS, Tate CC, Baumann MD, LaPlaca MC. Strategies for regeneration and repair in the injured central nervous system. In: Reichert WM, editor, Indwelling neural implants: strategies for contending with the in vivo environment. CRC Press, Boca Raton (FL); 2008. Chapter 8
   Google Scholar
• Radisic M, Park H, Shing H, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 2004;101:18129-34
   PubMed Web of Science ®Google Scholar
• Li SC, Tachiki LM, Luo J, et al. A biological global positioning system: considerations for tracking stem cell behaviors in the whole body. Stem Cell Rev 2010;6:317-33
   PubMed Web of Science ®Google Scholar
• Chao F, Shen Y, Zhang H, Tian M. Multimodality Molecular Imaging of Stem Cells Therapy for Stroke. Biomed Res Int 2013;2013:849819
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N Engl J Med 2006;355:2376-8
   PubMed Web of Science ®Google Scholar
• Andreas K, Georgieva R, Ladwig M, et al. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials 2012;33:4515-25
   PubMed Web of Science ®Google Scholar
• Barroso MM. Quantum dots in cell biology. J Histochem Cytochem 2011;59:237-51
   PubMed Web of Science ®Google Scholar
• McColgan P, Sharma P, Bentley P. Stem cell tracking in human trials: a meta-regression. Stem Cell Rev 2011;7:1031-40
   PubMed Web of Science ®Google Scholar
• Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44
   PubMed Web of Science ®Google Scholar
• Donovan WH. Donald Munro Lecture. Spinal cord injury – past, present, and future. J Spinal Cord Med 2007;30:85-100
   PubMed Web of Science ®Google Scholar
• Bottai D, Cigognini D, Madaschi L, et al. Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice. Exp Neurol 2010;223:452-63
   PubMed Web of Science ®Google Scholar
• Kumagai G, Okada Y, Yamane J, et al. Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury. PLoS One 2009;4:e7706
   PubMed Web of Science ®Google Scholar
• Lowry N, Goderie SK, Adamo M, et al. Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury. Exp Neurol 2008;209:510-22
   PubMed Web of Science ®Google Scholar
• Cui YF, Xu JC, Hargus G, et al. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery after spinal cord injury in mice. PLoS One 2011;6:e17126
   PubMed Web of Science ®Google Scholar
• Kerr CL, Letzen BS, Hill CM, et al. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 2010;120:305-13
   PubMed Web of Science ®Google Scholar
• Sharp J, Frame J, Siegenthaler M, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010;28:152-63
   PubMed Web of Science ®Google Scholar
• Erceg S, Ronaghi M, Oria M, et al. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 2010;28:1541-9
   PubMed Web of Science ®Google Scholar
• Salehi M, Pasbakhsh P, Soleimani M, et al. Repair of spinal cord injury by co-transplantation of embryonic stem cell-derived motor neuron and olfactory ensheathing cell. Iran Biomed J 2009;13:125-35
   PubMedGoogle Scholar
• Ruzicka J, Romanyuk N, Hejcl A, et al. Treating spinal cord injury in rats with a combination of human fetal neural stem cells and hydrogels modified with serotonin. Acta Neurobiol Exp (Wars) 2013;73:102-15
   PubMed Web of Science ®Google Scholar
• Watanabe K, Nakamura M, Iwanami A, et al. Comparison between fetal spinal-cord- and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury. Dev Neurosci 2004;26:275-87
   PubMed Web of Science ®Google Scholar
• Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res 2007;85:47-57
   PubMed Web of Science ®Google Scholar
• Erdogan B, Bavbek M, Sahin IF, et al. Fetal allogeneic umbilical cord cell transplantation improves motor function in spinal cord-injured rats. Turk Neurosurg 2010;20:286-94
   PubMed Web of Science ®Google Scholar
• Ziegler MD, Hsu D, Takeoka A, et al. Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp Neurol 2011;229:109-19
   PubMed Web of Science ®Google Scholar
• Collazos-Castro JE, Muneton-Gomez VC, Nieto-Sampedro M. Olfactory glia transplantation into cervical spinal cord contusion injuries. J Neurosurg Spine 2005;3:308-17
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Raisman G, Li D, Li Y. Transplanted olfactory mucosal cells restore paw reaching function without regeneration of severed corticospinal tract fibres across the lesion. Brain Res 2009;1303:26-31
   PubMed Web of Science ®Google Scholar
• Granger N, Blamires H, Franklin RJ, Jeffery ND. Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model. Brain 2012;135:3227-37
   PubMed Web of Science ®Google Scholar
• Tharion G, Indirani K, Durai M, et al. Motor recovery following olfactory ensheathing cell transplantation in rats with spinal cord injury. Neurol India 2011;59:566-72
   PubMedGoogle Scholar
• Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008;131:2376-86
   PubMed Web of Science ®Google Scholar
• Wu W, Lan Q, Lu H, et al. Transplantation of olfactory ensheathing cells for treatment of inflammatory demyelinating diseases in the central nervous system. Sci Res Essays 2010;5:3676-81
   Web of Science ®Google Scholar
• Yoshihara T, Ohta M, Itokazu Y, et al. Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury. J Neurotrauma 2007;24:1026-36
   PubMed Web of Science ®Google Scholar
• Raheja A, Suri V, Suri A, et al. Dose-dependent facilitation of peripheral nerve regeneration by bone marrow-derived mononuclear cells: a randomized controlled study: laboratory investigation. J Neurosurg 2012;117:1170-81
   PubMed Web of Science ®Google Scholar
• Sharma A, Gokulchandran N, Chopra G, et al. Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplant 2012;21(Suppl 1):S79-90
   Google Scholar
• Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005;11:913-22
   PubMedGoogle Scholar
• Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 2007;25:2066-73
   PubMed Web of Science ®Google Scholar
• Sigurjonsson OE, Perreault MC, Egeland T, Glover JC. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc Natl Acad Sci USA 2005;102:5227-32
   PubMed Web of Science ®Google Scholar
• Yazdani SO, Pedram M, Hafizi M, et al. A comparison between neurally induced bone marrow derived mesenchymal stem cells and olfactory ensheathing glial cells to repair spinal cord injuries in rat. Tissue Cell 2012;44:205-13
   PubMed Web of Science ®Google Scholar
• Karaoz E, Kabatas S, Duruksu G, et al. Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation. Turk Neurosurg 2012;22:207-17
   PubMed Web of Science ®Google Scholar
• Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004;187:266-78
   PubMed Web of Science ®Google Scholar
• Park JH, Kim DY, Sung IY, et al. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 2012;70:1238-47
   PubMed Web of Science ®Google Scholar
• Dai G, Liu X, Zhang Z, et al. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury. Brain Res 2013;1533:73-9
   PubMed Web of Science ®Google Scholar
• Jiang PC, Xiong WP, Wang G, et al. A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury. Exp Ther Med 2013;6:140-6
   PubMed Web of Science ®Google Scholar
• Pal R, Venkataramana NK, Bansal A, et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 2009;11:897-911
   PubMed Web of Science ®Google Scholar
• Frolov AA, Bryukhovetskiy AS. Effects of hematopoietic autologous stem cell transplantation to the chronically injured human spinal cord evaluated by motor and somatosensory evoked potentials methods. Cell Transplant 2012;21:S49-55
   Google Scholar
• Cristante AF, Barros-Filho TE, Tatsui N, et al. Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord 2009;47:733-8
   PubMed Web of Science ®Google Scholar